IDEXX Laboratories Inc (IDXX)
485.04
+8.16
(+1.71%)
USD |
NASDAQ |
May 07, 11:34
IDEXX Laboratories SG&A Expense (Quarterly): 241.48M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 241.48M |
December 31, 2023 | 229.05M |
September 30, 2023 | 224.73M |
June 30, 2023 | 230.20M |
March 31, 2023 | 217.90M |
December 31, 2022 | 214.98M |
September 30, 2022 | 213.78M |
June 30, 2022 | 211.74M |
March 31, 2022 | 210.24M |
December 31, 2021 | 211.92M |
September 30, 2021 | 206.53M |
June 30, 2021 | 192.36M |
March 31, 2021 | 185.58M |
December 31, 2020 | 185.63M |
September 30, 2020 | 213.23M |
June 30, 2020 | 154.45M |
March 31, 2020 | 181.96M |
December 31, 2019 | 180.36M |
September 30, 2019 | 170.89M |
June 30, 2019 | 161.32M |
March 31, 2019 | 166.94M |
December 31, 2018 | 154.88M |
September 30, 2018 | 159.10M |
June 30, 2018 | 157.34M |
March 31, 2018 | 161.03M |
Date | Value |
---|---|
December 31, 2017 | 145.86M |
September 30, 2017 | 146.00M |
June 30, 2017 | 143.15M |
March 31, 2017 | 140.16M |
December 31, 2016 | 131.38M |
September 30, 2016 | 132.60M |
June 30, 2016 | 130.97M |
March 31, 2016 | 129.12M |
December 31, 2015 | 125.29M |
September 30, 2015 | 119.30M |
June 30, 2015 | 120.14M |
March 31, 2015 | 117.74M |
December 31, 2014 | 122.50M |
September 30, 2014 | 116.30M |
June 30, 2014 | 109.87M |
March 31, 2014 | 108.94M |
December 31, 2013 | 104.84M |
September 30, 2013 | 98.73M |
June 30, 2013 | 96.75M |
March 31, 2013 | 101.03M |
December 31, 2012 | 84.57M |
September 30, 2012 | 87.37M |
June 30, 2012 | 88.81M |
March 31, 2012 | 93.81M |
December 31, 2011 | 83.38M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
154.45M
Minimum
Jun 2020
241.48M
Maximum
Mar 2024
201.92M
Average
210.99M
Median
SG&A Expense (Quarterly) Benchmarks
Stryker Corp | 1.84B |
Haemonetics Corp | 111.71M |
ResMed Inc | 229.92M |
Steris PLC | 360.52M |
Zoetis Inc | 547.00M |